Triple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine Kinases

Frank Hilberg, Norbert Kraut|Journal of Pharmacology and Experimental Therapeutics|2017

Cited by 105